Trent G. Kamke - 12 Mar 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Senior V. P., Operations
Signature
/s/ Nathan Ulrich
Issuer symbol
LMAT
Transactions as of
12 Mar 2025
Net transactions value
-$377,714
Form type
4
Filing time
14 Mar 2025, 16:53:04 UTC
Previous filing
04 Mar 2025
Next filing
31 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $47,332 +2,009 +36% $23.56 7,573 12 Mar 2025 Direct F1
transaction LMAT Common Stock Sale $164,979 -2,009 -27% $82.12 5,564 12 Mar 2025 Direct
transaction LMAT Common Stock Sale $319,948 -4,020 -72% $79.59 1,544 13 Mar 2025 Direct F2
transaction LMAT Common Stock Sale $40,126 -500 -32% $80.25 1,044 13 Mar 2025 Direct F3
transaction LMAT Common Stock Options Exercise $48,004 +1,353 +130% $35.48 2,397 14 Mar 2025 Direct F1
transaction LMAT Common Stock Options Exercise $6,172 +127 +5.3% $48.60 2,524 14 Mar 2025 Direct F1
transaction LMAT Common Stock Options Exercise $45,829 +1,229 +49% $37.29 3,753 14 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -2,009 -50% $0.000000 2,009 12 Mar 2025 Common Stock 2,009 $23.56 Direct F4
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,353 -25% $0.000000 3,978 14 Mar 2025 Common Stock 1,353 $35.48 Direct F4
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,229 -20% $0.000000 4,919 14 Mar 2025 Common Stock 1,229 $37.29 Direct F5
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -127 -2% $0.000000 6,200 14 Mar 2025 Common Stock 127 $48.60 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $79.08 to $79.98. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $80.08 to $80.34. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F4 This option is fully vested and exercisable.
F5 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.